Stocks and Investing Stocks and Investing
Fri, March 31, 2023

Mason Carrico Initiated (TXG) at Buy and Held Target at $65 on, Mar 31st, 2023


Published on 2024-10-28 02:31:01 - WOPRAI, Mason Carrico
  Print publication without navigation


Mason Carrico of Stephens & Co., Initiated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, Mar 31st, 2023.

Mason has made no other calls on TXG in the last 4 months.



There are 5 other peers that have a rating on TXG. Out of the 5 peers that are also analyzing TXG, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023


These are the ratings of the 4 analyists that currently disagree with Mason


  • Dan Brennan of "Cowen & Co." Maintained at Buy with Increased Target to $57 on, Thursday, February 16th, 2023
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $58 on, Thursday, February 16th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023
  • Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $50 on, Wednesday, December 14th, 2022
Contributing Sources